Companies: 10,795·Total market cap: $144.5T
Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

LUCDNASDAQHealthcare● Active
$0.96
$-0.01(-0.94%)
Market Cap$98017795
P/E Ratio—
52W High$1.629
52W Low$0.9
SEC Filings

Lucid Diagnostics Inc. (LUCD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001799011 · LUCD · NASDAQ · as of Jun 8, 2026

Filing snapshot

275
Total Filings
4
Latest Form
2026-05-21
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001799011 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-25
Fiscal Year End
Mar 25, 2026
Accession No.
0001437749-26-009805
Primary Document
lucd20251231_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001799011 · Accession 0001437749-26-009805

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-13
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-14Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-14
View
10-QQuarterly Report
FORM 10-Q
2026-05-13
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-30
View
ARSARS
ARS
2026-04-30
View
DEF 14AProxy Statement
DEF 14A
2026-04-30
View
3/AInitial Statement of Beneficial Ownership (Amended)
AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-24
View
8-KCurrent Report
8-K
2026-04-24
View
424B5424B5
424B5
2026-04-23
View
8-KCurrent Report
8-K
2026-04-23
View
PRE 14APRE 14A
PRE 14A
2026-04-20
View
3Initial Statement of Beneficial Ownership
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-13
View
S-8Employee Stock Plan Registration
S-8
2026-04-03
View
S-8Employee Stock Plan Registration
S-8
2026-04-03
View
EFFECTEFFECT
EFFECT
2026-03-26
View
424B5424B5
424B5
2026-03-26
View
Showing 1–15 of 212 filingsForm 4 / 144 hidden· 275 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001799011  |  Exchange: NASDAQ · Healthcare

Lucid Diagnostics Inc. (NASDAQ: LUCD) has submitted 275 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001799011, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lucid Diagnostics Inc.'s most comprehensive regulatory disclosure. The most recent Lucid Diagnostics Inc. 10-K was filed on 2026-03-25 for fiscal year ending 2026. Historical LUCD 10-K annual reports are available from 2020 through 2026.

Investors researching Lucid Diagnostics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
AVR SEC Filings →IRD SEC Filings →APYX SEC Filings →RCEL SEC Filings →SEER SEC Filings →RPID SEC Filings →OWLT SEC Filings →SCLX SEC Filings →
→ LUCD Financials→ LUCD Earnings→ LUCD Insider Trades

Frequently Asked Questions

LUCD SEC Filings · 8 questions

Lucid Diagnostics Inc. (LUCD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 275 filings and access original documents at no cost. Lucid Diagnostics Inc.'s CIK is 0001799011.

LUCD SEC filingsLucid Diagnostics Inc. SEC documentsfind LUCD 10-K